Analyst Research: Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

15.41USD
23 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
$15.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
599,405
52-wk High
$33.33
52-wk Low
$10.77

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
CLDX: Due Diligence Review: Forensic Earnings and Valuation 23 Oct 2014 New Constructs, LLC 9 25.00
Trading Report for (CLDX). A detailed report, including free correlated market analysis, and updates. 23 Oct 2014 Stock Traders Daily 6 20.00
Thomson Reuters Stock Report - CELLDEX THERAPEUTICS, INCORPORATION (CLDX-O) 23 Oct 2014 Thomson Reuters Stock Report 11 25.00
ValuEngine Rating and Forecast Report for CLDX 19 Oct 2014 ValuEngine, Inc. 11 25.00
CELLDEX THERAPEUTICS INC (CLDX) - REPORT FOR ACTIVE TRADERS 17 Oct 2014 Pechala's Reports 1 25.00
Value Graph: CELLDEX THERAPEU -- CLDX 16 Oct 2014 Ford Investor Services, Inc. 1 12.00
CELLDEX THERAPT (CLDX) Zacks Company Snapshot 16 Oct 2014 Zacks Investment Research Inc. 1 12.00
CELLDEX THERAPT (CLDX) Zacks Company Snapshot 15 Oct 2014 Zacks Investment Research Inc. 1 12.00
TheStreet.com Ratings Stock Report For: CELLDEX THERAPEUTICS INC (CLDX) 11 Oct 2014 TheStreet.com Ratings 5 10.00
CLDX.OQ - Event Transcript of Celldex Therapeutics Inc conference call, Sep. 08, 2014 / 1:25PM ET 8 Sep 2014 Thomson Reuters StreetEvents 11 75.00
 
Name Age Since Current Position

Larry Ellberger

66 2009 Independent Chairman of the Board

Anthony Marucci

52 2008 President, Chief Executive Officer, Director

Avery Catlin

66 2001 Chief Financial Officer, Senior Vice President, Secretary

Tibor Keler

55 2014 Executive Vice President, Chief Scientific Officer

Thomas Davis

50 2014 Executive Vice President, Chief Medical Officer
Search Stocks